Ligand Pharmaceuticals Inc
XBER:LGDN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Ligand Pharmaceuticals Inc
XBER:LGDN
|
US |
|
Mitsui Fudosan Co Ltd
OTC:MTSFF
|
JP |
|
A
|
Apple Inc
LSE:0R2V
|
US |
|
S
|
Sumitomo Corp
DUS:SUMA
|
JP |
|
Globe Life Inc
NYSE:GL
|
US |
|
Rheinmetall AG
F:RHMB
|
DE |
|
M
|
Mitsubishi Chemical Group Corp
DUS:M3C
|
JP |
|
Barrick Gold Corp
TSX:ABX
|
CA |
|
V
|
Vodafone Group PLC
XBER:VODJ
|
UK |
|
Pearson PLC
LSE:PSON
|
UK |
|
N
|
Natwest Group PLC
XHAM:RYS1
|
UK |
|
L
|
Leggett & Platt Inc
DUS:LP1
|
US |
|
N
|
NTT Data Group Corp
DUS:NT5
|
JP |
|
C
|
Credicorp Ltd
F:D8V
|
PE |
|
M
|
Mattel Inc
DUS:MTT
|
US |
|
E
|
Endeavour Silver Corp
XBER:EJD
|
CA |
|
Alpha Services and Holdings SA
OTC:ALBKF
|
GR |
|
Nippon Sanso Holdings Corp
F:NPX
|
JP |
|
G
|
Goldman Sachs Group Inc
BMV:GS
|
US |
|
D
|
Diageo PLC
SWB:GUI
|
UK |
|
Trustmark Corp
NASDAQ:TRMK
|
US |
|
S
|
Super Group Ltd
JSE:SPG
|
ZA |
|
Eenergy Group PLC
F:A1Z1
|
UK |
|
UFP Technologies Inc
F:UFP
|
US |
Dividends
Dividend Yield
Ligand Pharmaceuticals Inc
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Ligand Pharmaceuticals Inc
LGDN have decreased by 0%.
Payout Ratio
Ligand Pharmaceuticals Inc
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for LGDN is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
LGDN Price
Ligand Pharmaceuticals Inc
| Average Annual Return | 7.7% |
| Standard Deviation of Annual Returns | 47.3% |
| Max Drawdown | -68% |
| Market Capitalization | 6.3B EUR |
| Shares Outstanding | 17 960 000 |
| Percentage of Shares Shorted |
N/A
|
LGDN Return Decomposition
Main factors of price return
Stock Splits
LGDN's latest stock split occurred on Nov 19, 2010
The company executed a 1-for-6 stock split, meaning that for every 6 shares held, investors received 1 new share.
The adjusted shares began trading on Nov 19, 2010. This was the only stock split in LGDN's history.
